LabMedica

Download Mobile App
Recent News Expo Clinical Chem. Molecular Diagnostics Hematology Immunology Microbiology Pathology Technology Industry Focus

Crystallography Study Reveals Details of Angiotensin Receptor Structure

By LabMedica International staff writers
Posted on 11 May 2015
Image: This is an illustration of the effects of angiotensin on the AT1R (vasoconstriction, high blood pressure) compared to blocking the receptor (relaxed blood vessel, normal blood pressure) (Photo courtesy of USC - the University of Southern California).
Image: This is an illustration of the effects of angiotensin on the AT1R (vasoconstriction, high blood pressure) compared to blocking the receptor (relaxed blood vessel, normal blood pressure) (Photo courtesy of USC - the University of Southern California).
Researchers working with one of the world's most powerful free-electron X-ray lasers have established the crystal structure of the protein angiotensin II type 1 receptor (AT1R), an important blood pressure regulator in the human body.

Despite being the primary regulator for blood pressure maintenance, the structural basis for AT1R ligand-binding and regulation has remained elusive, mostly due to the difficulties of growing high-quality crystals for structure determination using synchrotron radiation. However, by applying the recently developed method of serial femtosecond crystallography at an X-ray free-electron laser, investigators at the University of Southern California (Los Angeles, USA) and their colleagues at Deutsches Elektronen-Synchrotron (Hamburg, Germany) successfully determined the room-temperature crystal structure of human AT1R in complex with its selective antagonist ZD7155 at 0.29 nanometers resolution.

The investigators wrote in a paper published in the April 23, 2015, online edition of the journal Cell that the AT1R-ZD7155 complex structure revealed key structural features of AT1R and critical interactions for ZD7155 binding. Docking simulations of the clinically used AT1R blockers (ARBs) into the AT1R structure further elucidated both the common and distinct binding modes for these anti-hypertensive drugs.

"Our work represents a first step in the direction of designing tailor-made blood pressure drugs with fewer side effects," said senior author Dr. Vadim Cherezov, professor of chemistry at the University of Southern California.

Related Links:

University of Southern California
Deutsches Elektronen-Synchrotron


New
Gold Member
Clinical Drug Testing Panel
DOA Urine MultiPlex
POC Helicobacter Pylori Test Kit
Hepy Urease Test
Automatic Hematology Analyzer
DH-800 Series
Hemodynamic System Monitor
OptoMonitor

Channels

Molecular Diagnostics

view channel
Image: The diagnostic device can tell how deadly brain tumors respond to treatment from a simple blood test (Photo courtesy of UQ)

Diagnostic Device Predicts Treatment Response for Brain Tumors Via Blood Test

Glioblastoma is one of the deadliest forms of brain cancer, largely because doctors have no reliable way to determine whether treatments are working in real time. Assessing therapeutic response currently... Read more

Immunology

view channel
Image: Circulating tumor cells isolated from blood samples could help guide immunotherapy decisions (Photo courtesy of Shutterstock)

Blood Test Identifies Lung Cancer Patients Who Can Benefit from Immunotherapy Drug

Small cell lung cancer (SCLC) is an aggressive disease with limited treatment options, and even newly approved immunotherapies do not benefit all patients. While immunotherapy can extend survival for some,... Read more

Microbiology

view channel
Image: New evidence suggests that imbalances in the gut microbiome may contribute to the onset and progression of MCI and Alzheimer’s disease (Photo courtesy of Adobe Stock)

Comprehensive Review Identifies Gut Microbiome Signatures Associated With Alzheimer’s Disease

Alzheimer’s disease affects approximately 6.7 million people in the United States and nearly 50 million worldwide, yet early cognitive decline remains difficult to characterize. Increasing evidence suggests... Read more

Technology

view channel
Image: Vitestro has shared a detailed visual explanation of its Autonomous Robotic Phlebotomy Device (photo courtesy of Vitestro)

Robotic Technology Unveiled for Automated Diagnostic Blood Draws

Routine diagnostic blood collection is a high‑volume task that can strain staffing and introduce human‑dependent variability, with downstream implications for sample quality and patient experience.... Read more

Industry

view channel
Image: Roche’s cobas® Mass Spec solution enables fully automated mass spectrometry in routine clinical laboratories (Photo courtesy of Roche)

New Collaboration Brings Automated Mass Spectrometry to Routine Laboratory Testing

Mass spectrometry is a powerful analytical technique that identifies and quantifies molecules based on their mass and electrical charge. Its high selectivity, sensitivity, and accuracy make it indispensable... Read more